Table 2. Patient, tumor, and treatment characteristics.
| Variables | N | % |
|---|---|---|
| Total patients | 36 | |
| Age at diagnosis, median [yr] | 63 [45-81] | |
| Gender | ||
| Male | 17 | 47.2 |
| Female | 19 | 52.8 |
| Histology | ||
| Adenocarcinoma | 35 | 97.2 |
| Adenosquamous carcinoma | 1 | 2.8 |
| Primary tumor location | ||
| Head | 30 | 83.3 |
| Body | 5 | 13.9 |
| Tail | 1 | 2.8 |
| Clinical T stage | ||
| 3 | 34 | 94.4 |
| 4 | 2 | 5.6 |
| Clinical N stage | ||
| 0 | 20 | 55.6 |
| 1 | 16 | 44.4 |
| Induction chemotherapy | ||
| GTX | 30 | 83 |
| Gemzar alone | 5 | 13.9 |
| Gemzar/cisplatin | 1 | 2.8 |
| Prescription RT dose to region of tumor-vessel abutment, median (Gy) | 35 (32.5-40) |
GTX, Gemzar, Taxotere, Xeloda.